16 employees
Intrommune Therapeutics is a New York-based biotechnology company.
2015
$6M
from 2 investors over 2 rounds
Intrommune Therapeutics raised $6M on June 1, 2021
Investors: Robin Hood Ventures and Red Bear Angels